- Home
- WHLR vs GTBP Comparison
WHLR vs GTBP Comparison
Compare WHLR & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- GTBP
- Stock Information
- Founded
- WHLR 2011
- GTBP 1965
- Country
- WHLR United States
- GTBP United States
- Employees
- WHLR N/A
- GTBP N/A
- Industry
- WHLR Real Estate Investment Trusts
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- GTBP Health Care
- Exchange
- WHLR Nasdaq
- GTBP Nasdaq
- Market Cap
- WHLR 4.2M
- GTBP 2.4M
- IPO Year
- WHLR 2012
- GTBP N/A
- Fundamental
- Price
- WHLR $3.86
- GTBP $0.73
- Analyst Decision
- WHLR
- GTBP Strong Buy
- Analyst Count
- WHLR 0
- GTBP 1
- Target Price
- WHLR N/A
- GTBP $11.00
- AVG Volume (30 Days)
- WHLR 162.8K
- GTBP 4.4M
- Earning Date
- WHLR 11-06-2025
- GTBP 11-13-2025
- Dividend Yield
- WHLR N/A
- GTBP N/A
- EPS Growth
- WHLR N/A
- GTBP N/A
- EPS
- WHLR N/A
- GTBP N/A
- Revenue
- WHLR $102,799,000.00
- GTBP N/A
- Revenue This Year
- WHLR N/A
- GTBP N/A
- Revenue Next Year
- WHLR N/A
- GTBP N/A
- P/E Ratio
- WHLR N/A
- GTBP N/A
- Revenue Growth
- WHLR N/A
- GTBP N/A
- 52 Week Low
- WHLR $3.41
- GTBP $0.55
- 52 Week High
- WHLR $18,130.00
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- WHLR 45.19
- GTBP 44.78
- Support Level
- WHLR $3.41
- GTBP $0.64
- Resistance Level
- WHLR $4.89
- GTBP $1.37
- Average True Range (ATR)
- WHLR 0.54
- GTBP 0.15
- MACD
- WHLR -0.33
- GTBP 0.03
- Stochastic Oscillator
- WHLR 12.41
- GTBP 20.61
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.